CITIGROUP INC - ANIKA THERAPEUTICS INC ownership

ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 167 filers reported holding ANIKA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of ANIKA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,696
-99.7%
91
-99.5%
0.00%
Q2 2023$520,016
-42.5%
20,016
-36.4%
0.00%
-100.0%
Q1 2023$904,134
+35.2%
31,481
+39.3%
0.00%0.0%
Q4 2022$668,842
-18.2%
22,596
-34.3%
0.00%0.0%
Q3 2022$818,000
+46.9%
34,380
+37.9%
0.00%
Q2 2022$557,000
+3.7%
24,938
+16.6%
0.00%
Q1 2022$537,000
-54.6%
21,379
-35.3%
0.00%
-100.0%
Q4 2021$1,183,000
+34.4%
33,032
+59.8%
0.00%0.0%
Q3 2021$880,000
-55.9%
20,676
-55.1%
0.00%0.0%
Q2 2021$1,995,000
+17.1%
46,078
+10.4%
0.00%0.0%
Q1 2021$1,703,000
+298.8%
41,748
+342.6%
0.00%
Q4 2020$427,000
+75.0%
9,432
+36.9%
0.00%
Q3 2020$244,000
-65.9%
6,890
-63.6%
0.00%
-100.0%
Q2 2020$715,000
+39.4%
18,940
+6.8%
0.00%
Q1 2020$513,000
-44.8%
17,733
-1.0%
0.00%
-100.0%
Q4 2019$929,000
-60.8%
17,906
-58.5%
0.00%
-50.0%
Q3 2019$2,370,000
+70.1%
43,183
+25.9%
0.00%
+100.0%
Q2 2019$1,393,000
+478.0%
34,290
+330.5%
0.00%
Q1 2019$241,000
-28.1%
7,966
-19.9%
0.00%
Q4 2018$335,000
-21.0%
9,948
-0.9%
0.00%
Q3 2018$424,000
+253.3%
10,038
+167.3%
0.00%
Q2 2018$120,000
-51.0%
3,755
-23.6%
0.00%
Q1 2018$245,000
-21.2%
4,915
-14.7%
0.00%
Q4 2017$311,000
-36.9%
5,765
-32.1%
0.00%
Q3 2017$493,000
-47.3%
8,493
-55.2%
0.00%
-100.0%
Q2 2017$935,000
+9.2%
18,955
-3.9%
0.00%0.0%
Q1 2017$856,000
-46.0%
19,726
-39.1%
0.00%0.0%
Q4 2016$1,584,000
+222.6%
32,367
+215.3%
0.00%
Q3 2016$491,000
+10.6%
10,266
+24.1%
0.00%
Q2 2016$444,000
-7.5%
8,273
-22.9%
0.00%
-100.0%
Q1 2016$480,000
+757.1%
10,737
+629.9%
0.00%
Q4 2015$56,0000.0%1,471
-16.4%
0.00%
Q3 2015$56,000
-34.9%
1,759
-32.3%
0.00%
Q2 2015$86,000
-23.2%
2,600
-4.6%
0.00%
Q1 2015$112,000
+28.7%
2,724
+28.1%
0.00%
Q4 2014$87,000
-56.3%
2,126
-60.9%
0.00%
Q3 2014$199,000
+1.0%
5,437
+28.0%
0.00%
Q2 2014$197,000
+20.9%
4,249
+7.0%
0.00%
Q1 2014$163,000
-44.6%
3,970
-48.4%
0.00%
Q4 2013$294,000
+153.4%
7,697
+59.3%
0.00%
Q3 2013$116,000
+11.5%
4,833
-20.7%
0.00%
Q2 2013$104,0006,0970.00%
Other shareholders
ANIKA THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Euclidean Technologies Management, LLC 44,875$2,031,0002.14%
Parian Global Management LP 102,705$4,648,0001.16%
CAPITAL MANAGEMENT CORP /VA 93,035$4,211,0001.15%
Avidity Partners Management LP 731,000$33,085,0001.07%
Sio Capital Management, LLC 65,382$2,959,0000.61%
DIKER MANAGEMENT LLC 21,835$988,0000.50%
Archon Capital Management LLC 48,925$2,214,0000.38%
Caption Management, LLC 362,800$16,420,0000.37%
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC 1,546,260$69,984,0000.20%
Boston Trust Walden Corp 378,167$17,116,0000.18%
View complete list of ANIKA THERAPEUTICS INC shareholders